Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Mitoxantrone is one of the few drugs approved for the treatment of progressive multiple sclerosis (MS). However, the prolonged use of this potent immunosuppressive agent is limited by the appearance of severe side effects. Apart from its general cytotoxic effect, the mode of action of mitoxantrone o...
Guardado en:
Autores principales: | Coralie Chanvillard, Jason M Millward, Marta Lozano, Isabell Hamann, Friedemann Paul, Frauke Zipp, Jan Dörr, Carmen Infante-Duarte |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c55664edcf084ee19141d3c0f2cddf6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MRI pattern recognition in multiple sclerosis normal-appearing brain areas.
por: Martin Weygandt, et al.
Publicado: (2011) -
Brain viscoelasticity alteration in chronic-progressive multiple sclerosis.
por: Kaspar-Josche Streitberger, et al.
Publicado: (2012) -
Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivity.
por: Mark Lyksborg, et al.
Publicado: (2014) -
Sequential actions of EOMES and T-BET promote stepwise maturation of natural killer cells
por: Jiang Zhang, et al.
Publicado: (2021) -
Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells
por: Jian-Xin Lin, et al.
Publicado: (2017)